Variations in infection control practices suggest a need for guidelines in primary ciliary dyskinesia patient care

Ayse B Caliskan1, Amjad Horani1,2, Michele Manion3

  • 1Department of Pediatrics, Division of Allergy and Pulmonary Medicine, School of Medicine, Washington University in Saint Louis, St. Louis, Missouri, USA.

Pediatric Pulmonology
|January 19, 2022
PubMed

Insights

Infection control practices for Primary Ciliary Dyskinesia (PCD) vary significantly among North American centers. The COVID-19 pandemic has increased mask use in outpatient settings, highlighting a need for standardized PCD care guidelines.

Area of Science:

  • Pulmonology
  • Infectious Disease Control
  • Genetics

Background:

  • Primary ciliary dyskinesia (PCD) is a genetic disorder impairing mucociliary clearance, leading to recurrent respiratory infections.
  • Drug-resistant organisms exacerbate infection frequency and lung function decline in PCD patients.
  • Current infection control practices in PCD care are not standardized, with limited data on protective gear usage.

Purpose of the Study:

  • To investigate current infection control and prevention strategies in North American PCD centers.
  • To assess the impact of the COVID-19 pandemic on these practices.
  • To identify the need for standardized infection control guidelines in PCD management.

Main Methods:

  • A web-based survey was distributed to PCD centers across North America.
  • The survey collected data on infection control practices before and after the COVID-19 pandemic.
  • A high response rate of 87.0% ensured robust data collection.

Main Results:

  • Pre-pandemic, the use of gloves, gowns, and masks in PCD care was inconsistent, with only 3.7% of centers using masks for outpatients.
  • Post-pandemic, 48.1% of centers plan to continue mask use during outpatient visits.
  • Practices regarding glove and gown use were not significantly influenced by the pandemic.

Conclusions:

  • Significant variability exists in infection control measures for Primary Ciliary Dyskinesia, underscoring the need for evidence-based guidelines.
  • Lessons learned from the COVID-19 pandemic regarding respiratory virus transmission mitigation may inform future PCD infection control strategies.
  • Standardized protocols are essential to improve patient outcomes and prevent the spread of infections in PCD care settings.

Related Concept Videos

Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.3K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.2K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
236
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.1K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K